First Republic Investment Management, Inc. Wave Life Sciences Ltd. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.89 - $7.12 $102,885 - $149,804	-21,040 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $1,649 - $2,185	-236 Reduced 1.11%	21,040 $166,000
Q3 2020 Nov 12, 2020	SELL	$8.49 - $19.54 $8,490 - $19,540	-1,000 Reduced 4.49%	21,276 $181,000
Q1 2020 May 13, 2020	BUY	$6.94 - $14.22 $154,595 - $316,764	22,276 New	22,276 $209,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

Ra Capital Management, L.P. Boston, MA

18.2M
Shares

$249 Million
2.08% of portfolio
Lee Ainslie Maverick Capital LTD | Dallas, Tx

10M
Shares

$137 Million
1.71% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.7M
Shares

$133 Million
0.15% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$92.1 Million
0.0% of portfolio
M28 Capital Management LP Stamford, CT

6.16M
Shares

$84.3 Million
48.05% of portfolio

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.19B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account